IL‐1, IL‐18, and IL‐33 families of cytokines
Top Cited Papers
- 1 June 2008
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 223 (1) , 20-38
- https://doi.org/10.1111/j.1600-065x.2008.00624.x
Abstract
Summary: The interleukin‐1 (IL‐1), IL‐18, and IL‐33 families of cytokines are related by mechanism of origin, receptor structure, and signal transduction pathways utilized. All three cytokines are synthesized as precursor molecules and cleaved by the enzyme caspase‐1 before or during release from the cell. The NALP‐3 inflammasome is of crucial importance in generating active caspase‐1. The IL‐1 family contains two agonists, IL‐1α and IL‐1β, a specific inhibitor, IL‐1 receptor antagonist (IL‐1Ra), and two receptors, the biologically active type IL‐1R and inactive type II IL‐1R. Both IL‐1RI and IL‐33R utilize the same interacting accessory protein (IL‐1RAcP). The balance between IL‐1 and IL‐1Ra is important in preventing disease in various organs, and excess production of IL‐1 has been implicated in many human diseases. The IL‐18 family also contains a specific inhibitor, the IL‐18‐binding protein (IL‐18BP), which binds IL‐18 in the fluid phase. The IL‐18 receptor is similar to the IL‐1 receptor complex, including a single ligand‐binding chain and a different interacting accessory protein. IL‐18 provides an important link between the innate and adaptive immune responses. Newly described IL‐33 binds to the orphan IL‐1 family receptor T1/ST2 and stimulates T‐helper 2 responses as well as mast cells.Keywords
This publication has 165 references indexed in Scilit:
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences, 2007
- P2X receptor characterization and IL‐1/IL‐1Ra release from human endothelial cellsBritish Journal of Pharmacology, 2007
- Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1Proceedings of the National Academy of Sciences, 2007
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007
- TNFα kinoid vaccination-induced neutralizing antibodies to TNFα protect mice from autologous TNFα-driven chronic and acute inflammationProceedings of the National Academy of Sciences, 2006
- Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptorProceedings of the National Academy of Sciences, 2006
- The role of inflammation in CNS injury and diseaseBritish Journal of Pharmacology, 2006
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003